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ABSTRACT
Advanced HIV causes substantial mortality in sub-Saharan Africa despite widespread antiretroviral
therapy coverage. This paper explores pathways of care amongst hospitalised patients with
advanced HIV in rural Kenya and urban Democratic Republic of the Congo, with a view to
understanding their care-seeking trajectories and poor health outcomes. Thirty in-depth
interviews were conducted with hospitalised patients with advanced HIV who had previously
initiated first-line antiretroviral therapy, covering their experiences of living with HIV and care-
seeking. Interviews were audio-recorded, transcribed and translated before being coded
inductively and analysed thematically. In both settings, participants’ health journeys were defined
by recurrent, severe symptoms and complex pathways of care before hospitalisation. Patients
were often hospitalised after multiple failed attempts to obtain adequate care at health centres.
Most participants managed their ill-health with limited support networks, lived in fragile
economic situations and often experienced stress and other mental health concerns. Treatment-
taking was sometimes undermined by strict messaging around adherence that was delivered in
health facilities. These findings reveal a group of patients who had “slipped through the cracks” of
health systems and social support structures, indicating both missed opportunities for timely
management of advanced HIV and the need for interventions beyond hospital and clinical settings.
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Background
In 2018, there were nearly 770,000 AIDS-related deaths
worldwide, with mortality rates remaining high in many
settings despite the widespread provision of antiretro-
viral therapy (ART) (Osler et al., 2018; UNAIDS,
2019). In contrast to the early years of ART roll-out in
sub-Saharan Africa, advanced HIV is now increasingly
seen amongst patients on treatment, indicating treat-
ment failure exacerbated by failings in the health sys-
tem, limited social support structures, and challenges
taking treatment over the long term (Chihana et al.,
2019; Merten et al., 2010; Skovdal et al., 2017). In
some settings, ART patients presenting at hospitals
with advanced HIV disease arrive in such severely
immunocompromised states that up to one-quarter
die within 48 hours of hospital admission (Ousley
et al., 2018).
A wealth of literature exists on the tensions between
the lived realities of people living with HIV (PLHIV)
and the features of HIV programmes. These tensions
are driven by health system barriers (Wringe, Renju,
et al., 2017), social and structural factors that underlie
late HIV diagnoses (Musheke et al., 2013) or late treat-
ment initiation following HIV diagnoses (Bukenya et al.,
2017; Horter et al., 2017; Wringe, Moshabela, et al.,
2017), and those that underpin challenges with adhering
to ART over time (e.g. Burns et al., 2019; Heestermans
et al., 2016; Nguyen et al., 2007). However, treatment-
experienced PLHIV with advanced HIV may provide
more extreme examples of these tensions that have con-
tributed to life-threatening illnesses despite access to
ART. Few studies have explored the experiences of
patients with advanced HIV since ART was introduced
(McCoy et al., 2009; Rao et al., 2013; Skovdal et al., 2019;
Tarimo et al., 2009), and very few have explored the
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perspectives of hospitalised PLHIV in African settings.
In studies conducted with hospitalised adolescents in
Botswana and Kenya, adolescents’ relationships to
family, clinic and peers defined their engagement and
retention in care (Enane et al., 2020) with reasons for
delayed care-seeking including caregiver illness and
death, and issues around disclosure of the adolescent’s
status linked to stigma (Enane et al., 2018). In a study
by Venables et al. among hospitalised PLHIV, experi-
ences of stigma, religious beliefs and limited economic
resources were linked to patients’ delayed access to
care (Venables et al., 2019).
Given the high mortality rates amongst patients with
advanced HIV, there is a pressing need for more
research to understand “what went wrong” in patients’
interactions with treatment and care services. Adher-
ence and care engagement have often been described
as cyclical (Merten et al., 2010; Skovdal et al., 2017),
with an estimated 25% of PLHIV on ART interrupting
their treatment at some stage (Kranzer & Ford, 2011).
Many researchers have argued for the need to move
beyond conceptualisations of patient engagement that
focus on their responsibility for appointment attend-
ance, treatment adherence, gratitude for care and alle-
giance to biomedical interventions (Paparini &
Rhodes, 2016; Russell et al., 2016). Examining pathways
of care amongst PLHIV may illuminate layers of exclu-
sion and inequity that make some of these individuals
particularly vulnerable to mortality and morbidity
risks in the context of fragile health systems in sub-
Saharan African settings. To inform interventions to
reduce mortality among patients with advanced HIV,
this study explored their pathways of care in rural




We draw on qualitative data that were collected as part
of a mixed-methods study that investigated drug resist-
ance to first-line ART and associated factors amongst
hospitalized patients with advanced HIV disease in
two hospitals supported by Médecins sans Frontières
(MSF) in Homa Bay, Kenya and Kinshasa, DRC
(Table 1). Advanced HIV was defined as CD4≤ 350
cells/µL. The quantitative component of this study
measured the proportion of treatment failure (virologi-
cal failure and major drug resistance mutations) among
these patients using a cross-sectional design.
Despite the differences between the settings, both
hospitals faced high rates of advanced HIV amongst
patients who were admitted with an HIV diagnosis.
In both sites, around half of all patients admitted to
hospital with HIV had been on ART for at least 6
months, and the majority were admitted with advanced
HIV. Mortality amongst HIV patients following hospi-
talisation was high in both settings: 30% died in hospi-
tal in Kinshasa and 17% in Homa Bay with an
additional 30% dying post-discharge after a median
observation time of 9 months in Homa Bay (Ousley
et al., 2018). The main causes of death amongst these
patients were tuberculosis and neurological infectious
diseases, including cryptococcal meningitis. 70% and
48% of participants in the cross-sectional study had
self-presented to the hospital in Homa Bay and Kin-
shasa respectively, and 25% and 23% had been hospi-
talised in the last three months indicating that
patients cycle in and out of hospital and may not access
timely referral when their health deteriorates (Bossard
et al., 2021). Prior to hospitalisation, patients in
Homa Bay had generally been receiving HIV care at
a government health centre (49%) or hospital (30%),






Sex M 7 7
F 8 8
Viral load (copies/ml) ≥1000 6 10
<1000 9 5
Time on ART (years) ≤4 8 5
>4 7 10
CD4 (cells/µL) <200 9 12
≥200 6 3
ART adherence (self-reported as % of









Table 1. Main characteristics of study sites.
Homabay County Teaching and Referral Hospital Centre hospitalier de Kabinda, Kinshasa
Setting Rural Urban
HIV prevalence High (Kenya 4.9%, Homa Bay sub-county 26%) Low (DRC 1.2%, Kinshasa 1.6%)
Hospital MoH with MSF support since 2014 (patient fees) MSF (free care since 2008)
% PLHIV admitted on ART >6 months 47% 56%
% PLHIV admitted with advanced HIV 84% 97%
In-hospital mortality among HIV patients 17% 30%
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and in Kinshasa at the MSF-supported hospital OPD
(38%) or a faith-based facility (23%).
Sampling strategy
Fifteen patients from each site participated in the quali-
tative component of the study (Table 2). Participants
had a median age of 40 years in Homa Bay and 39
years in Kinshasa and at the time of their interview a
median time of 4 years on ART in Homa Bay and 6
years in Kinshasa. Participants were sampled from the
cross-sectional component of the study for which eligi-
bility criteria included having initiated first-line ART at
least 6 months ago, with CD4≤ 350 cells/µL on presen-
tation to the hospital. A purposive sampling strategy
was used to ensure diversity in terms of sex, age, time
of treatment and self-reported ART adherence (Table
2). Patients were only eligible for the study if their clin-
ician considered them well enough to participate.
Patients were invited to participate by a Research Assist-
ant who also conducted the interview following written
informed consent.
Data generation
In-depth interviews took place between October and
November 2017 in Kinshasa, and between February
and April 2018 in Homa Bay. In Kinshasa, interviews
were conducted by a trained, non-clinical male Congo-
lese research assistant in Lingala or French in a quiet,
private room inside the ward. In Homa Bay, interviews
were conducted in Dholou (often with segments of Eng-
lish and Swahili) by a non-clinical, female, Kenyan
social scientist in a private outdoors location on the hos-
pital grounds. Interviews lasted for between 20 and
120 minutes, and covered participants’ lived experi-
ences of illness since their HIV diagnosis, their health
journeys, experiences with treatment and pathways of
care. Regular pauses were proposed during the interview
to enable the participant to rest.
Data management and analysis
Interviews were audio-recorded with consent, tran-
scribed and translated into either French (Kinshasa)
or English (Homa Bay) by a trained staffmember. Tran-
scripts were reviewed for quality, and any discrepancies
in translation were verified and corrected with the
assistance of the research assistants. Data from tran-
scripts were coded manually in Kinshasa and with the
aid of NVivo 11 software in Homa Bay. A thematic
analysis was undertaken by the research lead in each
site, drawing on the principles of grounded theory,
whereby codes were raised to a conceptual level consid-
ering their underlying meaning and their interrelation-
ship (Charmaz, 2014; Green & Thorogood, 2004).
Detailed analytical summaries of the emerging themes
and sub-themes were shared regularly between the
research leads in each site. Further refinement of the
analysis was undertaken by the lead author, with three
main themes emerging in relation to the study objective.
Ethics
Ethics approval was granted from the MSF Ethics
Review Board (Protocol ID: 1743), the KEMRI Scientific
and Ethics Review Committee in Kenya and the Comité
D’Ethique à la Recherche Scientifique in DRC.
Results
In both sites, participants usually self-presented at hos-
pital after their health had severely deteriorated. Three
main themes emerged from the analysis that character-
ised their pathways to hospitalisation: (i) social and
economic stresses; (ii) multiple and complex care jour-
neys and (iii) the burden of daily pill-taking and the
messaging around treatment and illness.
“I have a heavy heart”: social and economic
stress
Interviewees listed multiple and often severe symptoms
that resulted in their admission to hospital. Illness was
often prolonged, exemplified by issues like major weight
loss over time as one man from Kinshasa explained:
I weighed 75 kilos: because of the disease I lost weight
down to 42 kilos and then I weighed in here [at hospital]
at 39. [Man with advanced HIV, aged 30–40, Kinshasa]
Illness had compromised many participants’ liveli-
hoods, often with gendered consequences. Several men
reported stress at being unable to provide for their
families, while women’s major concerns tended to
revolve around caretaking for children, including mana-
ging school fees. These patients had often used their
limited resources without recovering from prior ill-
nesses, leaving some to worry about how they would
even be able to cover the costs of the hospital treatment
that was keeping them alive:
My treatment is going well, and I am getting better, but
when they will ask me to pay the bill, I will be stranded.
(Man with advanced HIV, aged 40–50 years, Homa Bay)
Some participants attributed various physical symp-
toms including stomach disorders, headaches and pain
to manifestations of stress. In both sites, participants’
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accounts revealed their mental health was linked to their
severe symptoms and dependence on others. Many felt
isolated and alone, and were concerned about who
would care for them when discharged, including cook-
ing and covering transport costs to return to hospital,
making service use, treatment taking and self-care oner-
ous. There was limited social support for those who had
not disclosed their HIV status to household members or
family. In some of the most extreme cases, participants
felt so desperate that they wanted to stop their drugs to
end their life:
No one has come to pay me a hospital visit, they don’t
care to know how my health is. I have also had challenges
at home. When they leave and go to the lake [for fishing]
no one remains at home. There is no one who can give
you even water to drink when you are down.… I have
a heavy heart… I have thought of committing suicide.
(Man with advanced HIV, aged 18-30, Homa Bay).
Men’s social stress at times centred on their role as a
husband, as defined by masculinity norms, including
their inability to maintain sexual relations with their
wives due to ill-health:
It is really disturbing me… as a man if I cannot have sex
with my wives… I don’t have peace… I have two wives,
but when it reaches the time when you want to engage
in such a thing…My libido just went down… how can
that be helped? (Man with advanced HIV, aged 40–50,
Homa Bay)
Some women who disclosed their HIV status to their
partners reported being unsupported, while most women
in the Homa Bay site reported violence perpetrated by
their partner, often including sexual violence. This further
undermined their resilience to living with HIV, to self-care
or to effectively seek help for their condition:
… every time I went to the clinic I would be told that my
viral load is high… I would tell him that maybe it is
because we are having sex without a condom…He is
very quarrelsome… I know that he (my partner) can
burn me in that house until I turn to ashes, I don’t I
know if I will wake up and find my cattle turned into
meat. This has really disturbed me. (Woman with
advanced HIV, aged 30–40, Homa Bay)
“I did not get healed”: complex pathways of care
Most participants reported multiple attempts to seek help
for their condition either at facilities where they normally
received HIV services, or at other sites such as government
clinics, primary health facilities, dispensaries, and in some
cases from pharmacies. Most participants eventually self-
presented at a hospital, revealing a pattern of inadequate
referral as their health deteriorated:
I had taken ARVs for about a year then a wound
appeared on my head. I went to Nyatoto but I did not
get healed… ‘Go to Nakuru there are dermatologists
there’ … they gave me ointments and oral drugs… go
to a hospital… a (sample) was to be taken to India for
testing… I was being told to go to Eldoret… I went to
Alupe and they gave oral medication and ointment. I
did not get healed…why was I wasting money? I just
bought the drug from the chemist… the pain was too
much, I felt I was dying. (Woman with advanced HIV,
aged 50–60, Homa Bay)
Repeated hospitalisation was also common, with
some participants too sick to collect their treatment,
thus deteriorating further, without adequate post-dis-
charge care or support. Decentralisation of HIV services
to community sites in Kinshasa meant that out-patients
sometimes waited until their next scheduled appoint-
ment to seek medical advice if they were sick:
I was late [attending the hospital] because of the appoint-
ment. I knew that I had an appointment on the 27th, but
before that I started to get some symptoms, so I told
myself that I would explain everything to the doctor
when I had my appointment. (Man with advanced
HIV, aged 30–40, Kinshasa)
Some participants reported negative or critical
responses from health workers over poor adherence or
missed appointments, and some felt intimidated to return
to care if they had previously disengaged from a service:
I made them angry since I could miss my appointed
dates… sometimes they even closed my file. When they
got angry, it was my mum who used to talk to them,
then they allowed me into the system again. (Man with
advanced HIV, aged 18–30, Homa Bay)
For other participants HIV was accepted as a lifelong,
chronic disease, and they perceived less urgency to seek
regular care unless their symptoms were severely affect-
ing their daily life. Community Health Workers and
peer-educators living with HIV often played a key role
in triaging patients with serious symptoms from
among those with minor health complaints, and in
urging the former to present at hospital, especially in
Homa Bay. Family support was also essential, with
most participants able to travel to a hospital due to
physical or financial support from caretakers.
“We were told that we should not take ARVs after
midday”: treatment-taking and making sense of
illness
Whilst adherence was impacted by social and econ-
omic stress, many participants recited strategies for
treatment adherence such as setting an alarm, keep-
ing a reserve for travel or having “treatment buddies”
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to help them. Despite these approaches, many partici-
pants faced challenges integrating pill-taking into
their daily lives, including managing timing of
doses which clashed with activities such as travel
for work. Some described treatment fatigue or
stopped taking pills during periods of good health,
or questioned their original diagnosis:
I got angry and I told them that I wouldn’t take my treat-
ment anymore because I don’t think it’s right… how
come I have AIDS and not my children? (Woman with
advanced HIV, aged 30–40, Kinshasa)
Treatment adherence and condom use were often
couched in moralized language or imbued with
shame, with some participants apologising for beha-
viours that they believed had led to their illness or treat-
ment failure. Overly strict treatment messages were
reportedly imparted by providers and discouraged
some participants from adhering if they could not
meet health workers’ expectations:
We were told that we should not take ARVs after mid-
day, that if you took them past that time then it will be
of no effect. (Man with advanced HIV, aged 40–50,
Kinshasa)
As a result, some participants skipped doses rather
than taking their drugs later than the recommended
time. Similarly, condom use was emphasised by health
workers as a primary way that participants could
avoid treatment failure through preventing “re-infec-
tion” with HIV. This was a common explanation pro-
posed by participants as to why their ART had
“stopped working” or why their health had deteriorated:
I think [I am sick] because of the regular sex we were
having. Having sex daily multiplies the virus in you. I
learned this when we went for counselling, that is
where we were taught that if have HIV, we have to use
a condom while having sex. (Woman with advanced
HIV, aged 40–50, Homa Bay)
Discussion
This study explored pathways of care amongst hospital-
ised patients with advanced HIV in DRC and Kenya to
understand their circumstances prior to hospital pres-
entation. Although people with advanced HIV infection
have a high mortality risk, few studies have explored
patients’ accounts of “what went wrong” which is an
essential precursor for ensuring that services provide
tailored and patient-centred care. Our findings chal-
lenge assumptions that advanced HIV is primarily an
issue of patient dis-engagement or “late” presentation
to care, notions which cast patients as personally
responsible for their ART adherence, without
acknowledging the social constraints and circumstances
that shape their engagement with care within global
HIV programming (Nguyen et al., 2007; Paparini &
Rhodes, 2016; Whyte et al., 2013). Many of our partici-
pants in both settings sought care multiple times as their
health declined without adequate service provision.
Despite its obvious benefits, decentralisation of HIV
care into primary health centres in African contexts
may create challenges in terms of delayed referral or
inadequate management of some patients, as our
findings suggested. Reducing the burden of advanced
HIV will require strengthening decentralised health ser-
vices to enable staff to identify the danger signs in
patients at risk of advanced HIV, provide timely case
management, ensure referral and provide post-dis-
charge support to those with ongoing clinical needs
(Ndlovu et al., 2020).
Our findings also indicate the need for patient sup-
port beyond clinical HIV interventions at a hospital
level, given that treatment and care success were often
influenced by mental health and experiences of violence
and economic hardship, factors which were often gen-
dered. The “triple epidemic” of HIV, gender-
based violence and mental health has been explored
elsewhere (Gilbert et al., 2015; Mitchell et al., 2016),
and there is increasing recognition that HIV program-
ming could be strengthened by addressing these health
concerns concurrently, for example through greater ser-
vice integration (Christofides & Jewkes, 2010; Chuah
et al., 2017). Furthermore, national HIV programmes
in many African settings are limited to counselling in
the context of HIV testing or ART adherence (Bird
et al., 2011; Mall et al., 2012), these existing services
could be reinforced to acknowledge the wider range of
mental health and social challenges faced by some
patients. Economic support or a reduction in patient
fees at the hospital level may also help some patients
cope with livelihood disruptions during illness as well
as reducing stress and anxiety which further undermine
positive health outcomes.
Our participants’ accounts of the challenges in inte-
grating treatment taking with their daily lives accord
with research undertaken elsewhere (Burns et al.,
2019; Heestermans et al., 2016; Merten et al., 2010).
Our findings also show the impact of social and econ-
omic stress on treatment taking. Overly strict messages
on pill-taking and moralised views on treatment failure
that were imparted by providers often discouraged pill-
taking or led to misunderstandings on how advanced
HIV could be prevented. In addition patients’ own per-
ceptions of their health may not align with clinical
assessments of the severity of their symptoms, as docu-
mented elsewhere (Venables et al., 2019).
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Our findings should be considered in light of various
limitations. Firstly, very few patients were well enough to
participate in an interview, limiting our ability to capture
the experiences of those with severe illness. Furthermore,
participants from both sites were interviewed in a hospital
setting, which may have generated reluctance to give nega-
tive feedback on the health services received. Where poss-
ible, this was mitigated by conducting the interviews
outside of the wards, by non-clinical interviewers who
were not involved in their care.
In conclusion, we found that hospitalised patients
with advanced HIV in both settings had remarkably
similar experiences that had led to extreme deterio-
rations in their health. Their pathways to hospitalisation
were marked by social and economic stresses, complex
care journeys as they engaged with multiple services
over time, and common experiences around the burden
of daily pill-taking alongside overly strict messaging
around treatment and illness. This analysis aids efforts
to understand the continued challenge of advanced
HIV in settings with widespread ART coverage. It high-
lights the need to address concurrent health and social
problems in tandem, rather than as separate threats,
considering that patients who develop advanced HIV
may be a sub-group of PLHIV who have “slipped
through the cracks” of health and social support
structures.
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